Saturday, May 18, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

These Endless Coronavirus Mutations

opening door to virus mutations

Shortly after the global campaign to control infection with the SARS-CoV-2 virus using mRNA COVID-19 shots began in the United States on Dec. 14, 2020, one of the concerns expressed by some scientists and doctors was that mass use of the bioengineered products might cause the virus to mutate  and lead to variants and subvariants, […]

Pfizer Drip Feeds Data from Its Pregnancy Trial

pregnant with photo

In January 2021, in the absence of any human data in pregnancy, the Centers for Disease Control and Prevention (CDC) stated on its website that mRNA vaccines were “unlikely to pose a specific risk for people who are pregnant.” Former CDC director Rochelle Walensky backed it up with a full-throated endorsement of covid-19 vaccination in pregnancy. “There is […]

U.S. Taxpayers Fund $5 Billion Project NextGen to Develop Novel COVID Vaccines and Drugs

more money for more COVID vaccines

Just three months after the Biden administration announced that U.S. taxpayers would fund a $5 billion initiative called Project NextGen to develop “next generation” COVID-19 vaccines and therapeutics, the U.S. Department of Health and Human Services’ (HHS) awarded $1.4 billion in contracts under the program on Aug. 22, 2023. The total includes “$1 billion for […]

Novel mRNA Lyme Shots Could Be Released in 2025

test tube and tick

Two novel messenger RNA (mRNA) shots for Lyme disease currently in late-stage clinical trials could hit the market as early as 2025, Moderna announced earlier this year. Also in the race to develop the first-ever mRNA product to prevent Lyme disease are Pfizer and Austria-based Valneva, which entered into a collaborative agreement in April 2020 […]

Safety and Effectiveness of New COVID Bivalent Boosters Based on a Study of Eight Mice?

one embarrassed mouse

With no safety and efficacy evidence from human clinical trials, on Aug. 31, 2022, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorizations (EUAs) for Pfizer/BioNTech’s Comirnaty and Moderna/NIAID’s Spikevax messenger RNA (mRNA) COVID-19 biologics to distribute “bivalent formulations” (two-in-one) of the shots to use as a “single booster dose.”1 2 The […]

Search in Site

To search in site, type your keyword and hit enter

Search